At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A 24 Week, Double-blind, Placebo-controlled, Multisite Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)
In Brief
A Phase 4 clinical trial evaluating Metanx (a medical food) and Metanx placebo for Type 2 Diabetic Peripheral Neuropathy (DPN). Completed, enrolled 214 participants across 6 sites.
Detailed Summary
The purpose of this research study is to determine if Metanx improves sensory neuropathy in persons with Type 2 diabetes. Metanx is a medical food available with a prescription from a physician. It consists of L-methylfolate, Pyridoxal 5'-phosphate, and Methylcobalamin, which are the active forms of folate, vitamin B6, and vitamin B12, respectively. Subjects will be randomly assigned to receive either Metanx or placebo for 6 months.
Study Details
Timeline
Interventions
Metanx one tablet twice a day
Metanx placebo one tablet twice a day